Evidence map›Paper›PMID 23474603›Full record

ArticleThe Journal of reproduction and development2013

Nicotinamide: a class III HDACi delays in vitro aging of mouse oocytes.

Ah Reum Lee, Satoshi Kishigami, Tomoko Amano, Kazuya Matsumoto, Teruhiko Wakayama, Yoshihiko Hosoi

Open access · goldAbstract read
In one paragraph

Article in The Journal of reproduction and development, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Can Nicotinamide Adenine Dinucleotide (NADAnimals : an open access journal from MDPI · 2024
    Review
  4. Impact of NAD+ metabolism on ovarian aging.Immunity & ageing : I & A · 2023
    Review
  5. NADThe Journal of reproduction and development · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Oocyte ageing and epigenetics.Reproduction (Cambridge, England) · 2015
    Review
  16. Article
  17. Abnormal lysine acetylation with postovulatory oocyte aging.Reproductive medicine and biology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ah Reum LeeDivision of Biological Science, Graduate School of Biology-Oriented Science and Technology, Kinki University, Wakayama 649-6493, Japan.
Satoshi Kishigami
Tomoko Amano
Kazuya Matsumoto
Teruhiko Wakayama
Yoshihiko Hosoi
Kindai University · JPUniversity of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postovulatory mammalian oocyte developmental potential decreases with aging in vivo and in vitro. Aging oocytes typically show cellular fragmentation and chromosome scattering with an abnormally shaped spindle over time. Previously, it was shown that histone acetylation in the mouse oocyte increased during aging and that treatment with trichostatin A (TSA), an inhibitor for class I and II histone deacetylases (HDACs), enhanced the acetylation, that is, aging. In this study, we examined the effect of nicotinamide (NAM), an inhibitor for class III HDACs, on in vitro aging of mouse oocytes as well as TSA. We found that treatment with NAM significantly inhibited cellular fragmentation, spindle elongation and astral microtubules up to 48 h of culture. Although presence of TSA partially inhibited cellular fragmentation and spindle elongation up to 36 h of culture, treatment with TSA induced chromosome scattering at 24 h of culture and more severe cellular fragmentation at 48 h of culture. Further, we found that α-tubulin, a nonhistone protein, increased acetylation during aging, suggesting that not only histone but nonhistone protein acetylation may also increase with oocyte aging. Thus, these data indicate that protein acetylation is abnormally regulated in aging oocytes, which are associated with a variety of aging phenotypes, and that class I/II and class III HDACs may play distinct roles in aging oocytes.

Indexed as

AnimalsApoptosisCellular SenescenceChromosomesFemaleGene Expression Regulation, DevelopmentalHistone Deacetylase InhibitorsHistone DeacetylasesHistonesHydroxamic AcidsMiceMicrotubulesNiacinamideOocytesOxidative StressPhenotypeHistone Deacetylase InhibitorsHistone DeacetylasesHistonesHydroxamic AcidsNiacinamidetrichostatin ATubulin

Identifiers

PMID23474603
PMCPMC3934134
OpenAlexW2086918518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.